MM
MMSI
MERIT MEDICAL SYSTEMS INC
$63.92
-0.88%
$3.8B
No data for this timeframe.
Vol
Market Cap$3.8B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (83%)
Inst. Holders9 funds
Inst. Value$1.1B
Inst. Activity2 buys / 0 sells
Insider Activity5B / 1S
Insider Net $$260.3K
Reddit Sentiment60° Warm
SEC Reports6
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. UT·CIK 0000856982·Prev Close $64.49
Recent Activity
May 20, 2026
Insider
Gunderson Thomas J. sold 13,750 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Gunderson Thomas J. sold 13,750 shares
Director @ $52.17 ($717.3K)
May 19, 2026
routine
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
<p>SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI)
May 18, 2026
Insider
Millner F. Ann Ed.D. sold 3,457 shares
Director @ $0.00 ($0.00)
May 13, 2026
SEC
Six MMSI insiders traded in a cluster from May 4-11, 2026, with five executives (including the CEO, CFO, and Chief Legal
CLUSTER — Impact 3/10
May 11, 2026
SEC
Four top executives at Merit Medical Systems, including the CEO, CFO, and Chief Legal Officer, collectively purchased $4
CLUSTER — Impact 6/10
Apr 30, 2026
SEC
Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street convention), beating the $0.83 consensus by 13.3%, and
PRESS-RELEASE — Impact 7/10
Inst.
NORGES BANK — NEW
861,781 shares ($76.0M)
Price Targets
$90.64
+41.8% upside
Strong Buy
Current $63.93
Low $74.00
Median $85.00
High $122.00
11 analysts
$74.00
$122.00
Analyst Ratings
7Strong Buy
8Buy
3Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 1, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 1, 2026 | JP Morgan | MAINTAIN | Overweight → Overweight |
| May 1, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
| May 1, 2026 | Needham | MAINTAIN | Buy → Buy |
| Apr 20, 2026 | Barrington Research | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.96 ▼ -8.7% | $0.94 — $0.98 | -5% YoY | 10 |
| Next Q | $1.02 ▼ -0.8% | $0.98 — $1.05 | 11% YoY | 10 |
| Current FY | $4.07 ▲ +1.6% | $4.03 — $4.13 | 6% YoY | 8 |
| Next FY | $4.40 | $4.25 — $4.58 | 8% YoY | 9 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Six MMSI insiders traded in a cluster from May 4-11, 2026, with five executives (including the CEO, CFO, and Chief Legal
May 13, 2026
BULLISH
CLUSTER
6/10
Four top executives at Merit Medical Systems, including the CEO, CFO, and Chief Legal Officer, collectively purchased $4
May 11, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $580.1M | — |
| FMR LLC | $156.1M | TRIM |
| MORGAN STANLEY | $100.5M | — |
| NORGES BANK | $76.0M | NEW |
| BANK OF AMERICA CORP | $64.6M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Gunderson Thomas | M | $0.00 |
| May 20, 2026 | Gunderson Thomas | M | $717.3K |
| May 18, 2026 | Millner F. | A | $0.00 |
| May 18, 2026 | McDonnell Michael | A | $0.00 |
| May 18, 2026 | Carpenter Lonny | A | $0.00 |
Reddit Sentiment
60°
Warm
Bearish
Neutral
Bullish
9 institutional holders with $1.1B total value (12,796,509 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 6,582,018 | $580.1M | 51.4% | — |
| 2 | FMR LLC | 1,771,579 | $156.1M | 13.8% | TRIM -36.2% |
| 3 | MORGAN STANLEY | 1,140,390 | $100.5M | 8.9% | — |
| 4 | NORGES BANK | 861,781 | $76.0M | 6.7% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 733,166 | $64.6M | 5.7% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 672,222 | $59.2M | 5.3% | NEW |
| 7 | WELLS FARGO & COMPANY/MN | 529,401 | $46.7M | 4.1% | — |
| 8 | TWO SIGMA INVESTMENTS, LP | 379,740 | $33.5M | 3.0% | TRIM -49.2% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 126,212 | $11.1M | 1.0% | ADD +68.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 861,781 | — | $76.0M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 74,912 | 126,212 | +68.5% | $11.1M | 2025-Q4 |
| FMR LLC | TRIM | 2,541,218 | 1,620,839 | -36.2% | $134.9M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 673,214 | 341,779 | -49.2% | $28.4M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 170,912 | 74,912 | -56.2% | $6.2M | 2025-Q3 |
| NORGES BANK | EXIT | 574,422 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 574,422 | — | $53.7M | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 711,386 | 956,147 | +34.4% | $101.1M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | ADD | 278,841 | 546,570 | +96.0% | $57.8M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 108,712 | 166,612 | +53.3% | $17.6M | 2025-Q1 |
| NORGES BANK | EXIT | 688,983 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | ADD | 1,033,044 | 1,417,352 | +37.2% | $137.1M | 2024-Q4 |
| CITADEL ADVISORS LLC | DOUBLED | 72,712 | 711,386 | +878.4% | $68.8M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 727,340 | — | $71.9M | 2024-Q3 |
15 unique insiders with 6 transactions. Net insider value: $260.3K ($573.3K bought, $313.0K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Gunderson Thomas J. | Director | M | 13,750 | $0.00 | $0.00 |
| May 20, 2026 | Gunderson Thomas J. | Director | M | 13,750 | $52.17 | $717.3K |
| May 18, 2026 | Millner F. Ann Ed.D. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | McDonnell Michael R. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Carpenter Lonny J. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Perez Silvia M. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Kaiser Laura S. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Evans Stephen C. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Gunderson Thomas J. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Ward Scott R. | Director | A | 3,457 | $0.00 | $0.00 |
| May 18, 2026 | Ward Lynne N. | Director | A | 3,457 | $0.00 | $0.00 |
| May 11, 2026 | Smith Christian Adam | Chief Commercial Officer | BUY | 1,626 | $61.00 | $99.2K |
| May 7, 2026 | Ward Lynne N. | Director | SELL | 5,000 | $62.61 | $313.0K |
| May 7, 2026 | Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY | BUY | 2,000 | $62.63 | $125.3K |
| May 6, 2026 | Parra Raul Jr. | CFO AND TREASURER | BUY | 1,500 | $61.01 | $91.5K |
| May 6, 2026 | Aronson Martha Goldberg | President and CEO | BUY | 2,000 | $60.44 | $120.9K |
| May 5, 2026 | Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | BUY | 2,250 | $60.65 | $136.5K |
| Feb 26, 2026 | Smith Christian Adam | Chief Commercial Officer | A | 8,203 | $0.00 | $0.00 |
| Feb 26, 2026 | Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY | A | 10,254 | $0.00 | $0.00 |
| Feb 26, 2026 | Peterson Neil W. | CHIEF OPERATING OFFICER | A | 7,690 | $0.00 | $0.00 |
| Feb 26, 2026 | Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | A | 7,690 | $0.00 | $0.00 |
| Feb 26, 2026 | Aronson Martha Goldberg | President and CEO | A | 28,198 | $0.00 | $0.00 |
| Feb 26, 2026 | Parra Raul Jr. | CFO AND TREASURER | A | 12,305 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 4 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.5/10.
NEUTRAL
CLUSTER
3/10
Six MMSI insiders traded in a cluster from May 4-11, 2026, with five executives (including the CEO,
May 13, 2026
BULLISH
CLUSTER
6/10
Four top executives at Merit Medical Systems, including the CEO, CFO, and Chief Legal Officer, colle
May 11, 2026
BULLISH
PRESS-RELEASE
7/10
Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street convention), beating the $0.83 con
Apr 30, 2026
BULLISH
COURT-RULING
6/10
The U.S. Court of Appeals for the Federal Circuit dismissed an appeal filed by Nazir Khan against Me
Apr 16, 2026
NEUTRAL
8-K
3/10
Merit Medical Systems disclosed historical revenue data disaggregated by its new foundational and th
Apr 13, 2026
BULLISH
8-K, 8-K
8/10
Merit Medical reported strong fourth quarter and full year 2025 results, with revenue of $393.9 mill
Feb 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (83% buy). Based on 18 analysts: 7 strong buy, 8 buy, 3 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$90.64 mean target
+41.8% upside
Strong Buy (1.82)
$74.00 Low
$122.00 High
| Metric | Value |
|---|---|
| Current Price | $63.93 |
| Target Low | $74.00 |
| Target Mean | $90.64 |
| Target Median | $85.00 |
| Target High | $122.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (1.82) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.96 | $0.94 | $0.98 | -4.9% | -8.7% | 0↑ 1↓ | $0.4B | 6.0% | 10 |
| Next Q 2026-09-30 |
$1.02 | $0.98 | $1.05 | 11.3% | -0.8% | 0↑ 1↓ | $0.4B | 6.4% | 10 |
| Current FY 2026-12-31 |
$4.07 | $4.03 | $4.13 | 6.3% | +1.6% | 1↑ 0↓ | $1.6B | 6.9% | 8 |
| Next FY 2027-12-31 |
$4.40 | $4.25 | $4.58 | 8.2% | +0.3% | 1↑ 0↓ | $1.7B | 6.0% | 9 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.961 | |
| 7d ago | $0.961 | |
| 30d ago | $1.052 | -0.092 |
| 60d ago | $1.069 | -0.109 |
| 90d ago | $1.061 | -0.101 |
7 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 1, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 1, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| May 1, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| May 1, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 20, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Apr 17, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Apr 7, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| Apr 1, 2026 | Needham | REITERATE | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Feb 25, 2026 | Barrington Research | MAINTAIN | Outperform | Outperform |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 18, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 6, 2026 | BTIG | INITIATE | — | Buy |
| Jan 9, 2026 | Needham | REITERATE | Buy | Buy |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 7 | 8 | 3 | 0 | 0 | 83% | |
| Apr 1, 2026 | 7 | 8 | 3 | 0 | 0 | 83% | |
| Mar 1, 2026 | 7 | 8 | 3 | 0 | 0 | 83% | |
| Feb 1, 2026 | 6 | 9 | 2 | 0 | 0 | 88% | |
| Jan 1, 2026 | 6 | 9 | 2 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
60°
Warm
Bearish
Neutral
Bullish
1 mentions
1 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 19, 2026
routine
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
<p>SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of he
May 8, 2026
other
Merit Medical to Participate in the Bank of America Healthcare Conference
<p align="justify">SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer an
May 6, 2026
short_volume
Short Volume: MMSI — 58.8% short (0.4M / 0.6M)
Short: 359,619 | Exempt: 0 | TRF Vol: 611,968 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
earnings
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
<p><strong>Financial Highlights†</strong></p>
Apr 30, 2026
earnings_calendar
MMSI Q1 2026 Earnings After Market Close — 2026-04-30
Apr 16, 2026
Enforcement
Khan v. Merit Medical Systems, Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 26-1334
Apr 2, 2026
earnings
Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
<p align="justify">SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare
Apr 1, 2026
m_and_a
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
<p>SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, toda
Mar 16, 2026
other
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients
Mar 13, 2026
short_interest
FTD: MMSI — 31,330 shares ($2.1M) failed to deliver
Settlement: 20260313, Price: $68.17, FTD Value: $2,135,766.1, MERIT MEDICAL SYSTEMS INC
Feb 24, 2026
earnings_calendar
MMSI Q4 2025 Earnings After Market Close — 2026-02-24
Feb 19, 2026
short_interest
FTD: MMSI — 28,327 shares ($2.4M) failed to deliver
Settlement: 20260219, Price: $82.98, FTD Value: $2,350,574.46, MERIT MEDICAL SYSTEMS INC